In this paper, we first recall the three restrictive hypotheses outside which it is not possible to speak of an optimum, and then we specify in which context (decision aid) this article is located.

Dave Miller, PhD, explains how early formulation planning, novel platforms, and tailored approaches secure long-term protection against generics. In this final part of our 5-part interview series on ...